By Lana Pine | Published on December 17, 2025 4 min read A large real-world study published in Neurology found that people with Type 2 diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists had a lower risk of developing epilepsy than those taking dipeptidyl peptidase-4 (DPP-4) inhibitors
You can read our post about what happens after coming off GLP-1s
In correspondence to total CA1 pyramidal neuron counts, SAMP8 mice treated with the low, but not high, dose of liraglutide therefore showed a significantly higher CA1 pyramidal neuron density (631,611 15,719 neurons/mm 3 ), as compared to vehicle-dosed SAMP8 mice (551,563 15,432 neurons/mm 3 , p 3.0.co;2-5
The test includes: Cognitive and memory assessments evaluating processing speed, attention, and recall
In the United States, hGH is legal only as a prescription medication and is not available over the counter
For mild symptoms , you can typically continue your GLP-1 medication while focusing on aggressive hydration and rest
&srotate=0)
